Commercialization & investment in biotechnology are key forces transforming laboratory discoveries into real-world applications that benefit health, industry, and the environment. This domain bridges the gap between research innovation and market readiness, involving intellectual property strategies, regulatory navigation, and business model development. Investors, venture capitalists, and corporate partners play a crucial role in funding early-stage biotech startups, clinical trials, and manufacturing scale-up. Commercialization & Investment in Biotechnology also include public-private partnerships and technology transfer offices that support licensing and entrepreneurship. As competition intensifies, strategic alliances and investor confidence hinge on strong scientific validation, scalable platforms, and clear regulatory pathways. This process not only accelerates product development but ensures that scientific breakthroughs reach patients, consumers, and industries worldwide.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico